UNSPSC 51282951: Nalidixic acid

This classification denotes a urinary anti-infective agent and quinolone antibiotic with the molecular formula C12H12N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3B91HWA56M, chemically known as 1,8-naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo- but generally known as nalidixic acid, which bears US NIH Compound Identifier 4421. European Medicines Agency schedules Nalidixic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09138MIG.

UNSPSC 51282951 Nalidixic acid is a Commodity code that in recent state and local solicitations covers pharmaceutical procurement and emergency medical supply acquisition, though the actual opportunities tagged under this code diverge significantly from the nominal substance name. State and local buying under this code reflects purchases of naloxone and drug deactivation systems for public health initiatives, generic pharmaceuticals and over-the-counter products distributed through cooperative purchasing networks, and medical and first aid supplies for emergency response divisions. The issuing bodies include county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing alliances spanning multiple jurisdictions. The code sees activity across health department procurement, pharmacy benefit program modernization efforts, and fire and rescue operations—suggesting a broader application to pharmaceutical and medical supply procurement than the code's specific chemical designation implies.

Geographic activity centers on Florida and Minnesota, with Texas representing significant state-level procurement interest. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023. The City of Tampa's Purchasing Department issued ITB 26-P-00145 in March 2026 for medical and first aid supplies (estimated value $700,000) for the Tampa Fire Department Rescue Division with a sheltered-market set-aside for Small Local Business Enterprises and a 5 percent SLBE bid discount (not to exceed $10,000). The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026 and distribution through three authorized wholesalers. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 exploring vendor capabilities for direct-to-manufacturer prescription programs as a market-intelligence phase preceding formal procurement.